Submit your Palladone claim details for a free, no obligation case review
Get Started:
Due to the serious and fatal Palladone risk discovered in clinical trials, this potent narcotic was pulled from the shelves less than six months after it was first approved for use in the United States. On July 13, 2005 the FDA asked Purdue, the makers of Palladone, to pull this dangerous drug off the shelf. This FDA request was prompted by clinical findings about a serious Palladone risk.
The Palladone risk was discovered in a Purdue-sponsored trial, which revealed that Palladone can cause a fatal drug reaction when mixed with alcohol. The study found that even one alcoholic beverage could trigger dose dumping in patients taking Palladone. Dose-dumping is the rapid release of a time-released medication into the bloodstream. Because of the nature and potency of Palladone, the combination of Palladone and alcohol can lead to a fatal overdose.
Before this Palladone risk was discovered, this potent drug was approved to treat persistent moderate to severe pain for an extended period of time. Palladone was intended only for those patients who had developed a tolerance to opioids and had been unsuccessful with shorter-acting medications. People who haven’t developed a tolerance to opioids before taking this drug face the fatal Palladone risk of respiratory depression.
The biggest Palladone risk, which is essentially the same risk posed by alcohol consumption, is overdose. Palladone time-released pills were designed to be swallowed whole so that the active ingredient could be slowly released into the body for consistent pain relief. A serious Palladone risk involves chewing, crushing, dissolving, or breaking the pills for consumption. This causes too much Palladone to flood the system, which can lead to a fatal overdose.
Palladone pills may be abused in this way because ingestion of a large amount of opioid can produce euphoric feelings. This touches on another Palladone risk: the potential for abuse. Drug abusers often seek drugs like Palladone for misuse without knowing or caring about the fatal Palladone risk associated with abusing this medication. Palladone abuse is also dangerous because drugs of its kind are extremely addictive.
A Palladone overdose can severely depress the central nervous system. Symptoms of a Palladone overdose can include: slowed breathing, sleepiness, stupor, muscle flaccidity, cold clammy skin, slowed heart rate, low blood pressure, and constricted pupils. When the Palladone risk is serious, overdose can lead to respiratory depression, lung failure, and death. An overdose from Palladone requires at least 18 hours of continuous monitoring and treatment in order to stabilize the patient and mitigate the Palladone risk of death.
Purdue has estimated that 11,500 people took Palladone before the recall. If you or a loved one has taken this medication and are concerned about the fatal Palladone risk, please contact us to confer with a qualified and experienced attorney who can evaluate your case to ensure that your legal interests are protected.
The U.S. Food and Drug Administration has asked Purdue Pharma to stop the sale and marketing of its potent new pain drug, Palladone, after just five months on the market. The decision was made after the agency acquired new information regarding the in...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice